NCT03108066 2024-09-24MK-3795-003Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)Phase 2 Completed4 enrolled 11 charts
NCT00052013 2017-03-06Treatment of Von Hippel-Lindau (VHL)-Related Hemangioblastoma With PTK787/ZK 222584NovartisPhase 2 Completed11 enrolled